Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | SLC6A1 | P30531 | 2/20 | 0.48 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | SLC6A13 | Q9NSD5 | 1/20 | 0.48 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.48 |
| ▸ | ANPEP | P15144 | 1/20 | 0.47 |
| ▸ | BTK | Q06187 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | GABRP | O00591 | 1/20 | 0.43 |
| ▸ | GABRD | O14764 | 1/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.43 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.43 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.43 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.43 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.43 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.43 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29844 | 1.00 | ACE (0.48) | ACETSHRSLC6A1SLC6A11LMNA | |
| SCHEMBL35888 | 1.00 | ACE (0.48) | ACETSHRSLC6A1SLC6A11LMNA | |
| SCHEMBL17041334 | 1.00 | ACE (0.48) | ACETSHRSLC6A1SLC6A11LMNA | |
| SCHEMBL2049696 | 1.00 | ACE (0.48) | ACETSHRSLC6A1SLC6A11LMNA | |
| SCHEMBL13868097 | 1.00 | ACE (0.48) | ACETSHRSLC6A1SLC6A11LMNA | |
| SCHEMBL20262981 | 0.97 | ACE (0.46) | ACETSHRSLC6A1SLC6A11LMNA | |
| Hydrochloric Acid SCHEMBL7641498 | 0.97 | ACE (0.46) | ACETSHRSLC6A1SLC6A11LMNA | |
| Ammonia Solution, Strong SCHEMBL21463027 | 0.97 | ACE (0.46) | ACETSHRSLC6A1SLC6A11LMNA | |
| SCHEMBL6740705 | 0.97 | ANPEP (0.50) | ACETSHRSLC6A1SLC6A11LMNA | |
| Bromide SCHEMBL7786835 | 0.97 | ACE (0.46) | ACETSHRSLC6A1SLC6A11LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 728 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119751086-A | Coating-modified refractory ceramic powder based on metal organic framework and preparation method and application thereof | 华中科技大学 | 2025-04-04 | — | — | CN | claimed |
| EP-4159792-A1 | SEMI-CRYSTALLINE POLYAMIDE COMPOSITION WITH A HIGH GLASS TRANSITION TEMPERATURE BASED ON SHORT DIAMINE FOR THERMOPLASTIC MATERIAL, METHOD FOR MAKING SAME AND USES THEREOF | ARKEMA FRANCE (FR) | 2023-04-05 | — | — | EP | claimed |
| CN-115110072-B | Environment-friendly chemical copper deposition solution for circuit board and copper deposition method | 深圳市板明科技股份有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-115110072-A | Environment-friendly chemical copper deposition solution and copper deposition method for circuit board | 深圳市板明科技股份有限公司 | 2022-09-27 | — | — | CN | claimed |
| CN-113698585-A | Preparation method of biodegradable glycolide- (alicyclic-co-aromatic) -glycolide block copolyester | 浙江恒澜科技有限公司 | 2021-11-26 | — | — | CN | claimed |
| CN-108778686-B | Fused filament printing | 帝斯曼知识产权资产管理有限公司 | 2021-11-16 | — | — | CN | claimed |
| US-11168227-B2 | Fused filament printing | COVESTRO (NETHERLANDS) B.V. (NL) | 2021-11-09 | — | — | US | claimed |
| EP-3609990-B1 | POLYMERS AS ADDITIVES FOR FUELS AND LUBRICANTS | BASF SE (DE) | 2021-10-27 | — | — | EP | claimed |
| CN-106939125-B | Flame-resistant semi-aromatic polyamide moulding compositions | EMS 专利股份公司 | 2020-12-29 | — | — | CN | claimed |
| US-10731002-B2 | Semiaromatic copolyamide resin and polyamide molding composition consisting of the same | KINGFA SCI. & TECH. CO., LTD. (CN) | 2020-08-04 | — | — | US | claimed |
| EP-2155162-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | Bausch & Lomb Incorporated (US) | 2010-02-24 | — | — | EP | claimed |
| EP-1988113-B1 | Partially aromatic polyamide moulding masses and their applications | EMS PATENT AG (CH) | 2009-10-14 | — | — | EP | claimed |
| WO-2008137496-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | BAUSCH & LOMB INCORPORATED (US) | 2008-11-13 | — | — | WO | claimed |
| US-20080280853-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | BAUSCH & LOMB INCORPORATED | 2008-11-13 | — | — | US | claimed |
| WO-2008137826-A2 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | BAUSCH & LOMB INCORPORATED (US) | 2008-11-13 | — | — | WO | claimed |
| US-20080275000-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | SALIX PHARMACEUTICALS, INC. | 2008-11-06 | — | — | US | claimed |
| US-20080274355-A1 | SEMIAROMATIC POLYAMIDE MOLDING COMPOSITIONS AND THEIR USE | EMS-PATENT AG (CH) | 2008-11-06 | — | — | US | claimed |
| EP-0543264-B1 | Rewritable thermosensitive recording medium | TOPPAN PRINTING CO LTD (JP) | 1995-05-03 | — | — | EP | claimed |
| US-5278129-A | Low molecular weight alicyclic dicarboxylic acid | TOPPAN PRINTING CO., LTD. (JP) | 1994-01-11 | — | — | US | claimed |
| EP-0543264-A1 | Rewritable thermosensitive recording medium | Toppan Printing Co., Ltd. (JP) | 1993-05-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080275000-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | PDE6D, PDE6H, CA2 | ACE 1039/4885TSHR 2300/4885SLC6A1 960/4885 |
| US-20080280853-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | CA2, IDUA, CA6 | ACE 489/4885TSHR 3016/4885SLC6A1 532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.